Clinical Development Consulting (SPO) Model

all services

opening hours

Need Help? Call Here

+19196079071

Clinical Development 
C
o
n
s
u
l
t
i
n
g
(
S
P
O
)
 O
v
e
r
i
e
w

Our Strategic Consulting services are an integral part of our SPEOTM Model, which is designed and tailored to provide unique solutions to our clients on their drug development needs as well as empowering them with the right functional expertise to drive their current needs.

Our SPEOTM Model also helps quick scale up as the project scope changes and will play an integral role in your company's scale-up process.

The PAR Clinical Team is seasoned in strategically managing clinical programs and can support creating Target Product Profiles, Asset Prioritization, and structuring your program to enable rational and timely decisions to reduce time to market.

Clinical Development Strategy

  • Review of pre-clinical package and perform gap analysis. Program manage pre-clinical vendors to support continued pre-clinical package development.
  • Build clinical development strategies to optimize and expedite time to market. Develop CDPs, TPPs, Study Design, and planning.
  • Asset Prioritization.
  • KOL engagement
  • Functional Consultants to support clinical development: Pharmacologist, DMPK, Translational Meds, Toxicologist, Analytical Chemist

Regulatory Strategy, Affairs and Operations

  • Data Package evaluation, GAP Analysis, and develop robust submission strategies. Briefing document development, Regulatory meeting prep, and representative services
  • Regulatory, Strategic, and Operational support for major filings.
  • Writing and review of CTD modules (IND/CTA/BLA/ANDA)
  • Publishing of IND/CTA/BLAs/NDAs

Clinical Program Management and Development Operations

  • Life Cycle management and strategy building.
  • Oversee the entire development lifecycle from pre-clinical package development to clinical execution.
  • Regulatory program management IND /CTA development.
  • Risk Mitigation and periodic Risk reevaluation.
  • As part of the Oversight Model (FSP), provide sponsor oversight from IND to Clinical Studies
  • Implementation of BIMO elements into clinical trials and project management
  • Infrastructure development to support scale-up activities

GXP Quality

  • Perform GMP, GCP, and GPV audits
  • Inspection Readiness Activities
  • Build GXP Quality Systems